-
PENELOPE-B Trial Shows Mixed Palbociclib Results in Breast Cancer Subtypes
08 Apr 2025 23:30 GMT
… (HR)–positive, HER2-negative breast cancer with residual disease …
In patients with lobular breast cancer, those who received palbociclib … patients with [lobular breast cancer], particularly those with … risk HR+/HER2- breast cancer and residual disease …
-
Dato-DXd Secures EU Approval for Pretreated HR+/HER2– Metastatic Breast Cancer
08 Apr 2025 19:23 GMT
… hormone receptor–positive, HER2-negative breast cancer who have received prior … hormone receptor–positive, HER2-negative breast cancer presents challenges, particularly … hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Primary …
-
Tahira Kashyap's breast cancer relapses after 7 yrs; doctor explains its causes and important tests to undergo
08 Apr 2025 12:56 GMT
… to share that her breast cancer has relapsed for … tumour. Breast cancer subtypes; such as hormone receptor-positive, HER2-positive … the treatment received. For breast cancer, for example, the … standard for patients with breast cancer, especially if the …
-
AZ, Daiichi get EU okay for breast cancer drug Datroway
08 Apr 2025 12:55 GMT
… drug conjugate (ADC) for breast cancer, Datroway, the latest to … metastatic HR-positive, HER2-negative breast cancer who have previously been … similar HR-positive, HER2-negative breast cancer population in 2023 … , who leads the breast cancer unit at the Gustave …
-
DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
08 Apr 2025 06:51 GMT
… About Hormone Receptor Positive, HER2 Negative Breast Cancer
Breast cancer is the second most … HR positive, HER2 negative breast cancer (measured as HER2 score of IHC … , triple negative breast cancer and HR positive, HER2 negative breast cancer. The program …
-
Experimental breast cancer vaccine creates unique bond between Moffitt patient, cell therapy technologist
08 Apr 2025 03:06 GMT
… - An experimental breast cancer vaccine at Moffitt Cancer … that helped defeat her breast cancer. READ: Several … therapy for breast cancer, and personalized treatment for breast cancer patients. … diagnosed with Stage 2, HER2+ breast cancer in March 2024.
…
-
Dr Zhang on the Rationale of Evaluating SIM0270/Everolimus in ER+/HER2– Advanced Breast Cancer
07 Apr 2025 23:34 GMT
… in estrogen receptor–positive breast cancer].”
Jian Zhang, MD, … positive/HER2-negative advanced breast cancer in a phase … -positive/HER2-negative advanced breast cancer, the combination … positive/HER2-negative advanced breast cancer after prior CDK4 …
-
Dr McCann on the Increasing Use of TKIs for HER2+ Breast Cancer Brain Metastases
07 Apr 2025 23:34 GMT
… treatment of patients with HER2-positive breast cancer, particularly those with brain … option for patients with HER2-positive breast cancer and CNS involvement, McCann … paradigm for patients with HER2-positive breast cancer and brain metastases, McCann …
-
Breaking Down Lipid Storage in Triple Negative Breast Cancer Cells May Help Overcome Treatment Resistance
07 Apr 2025 22:44 GMT
… resistance in triple-negative breast cancer (TNBC), according to … growth factor receptor 2 (HER2) in tumor cells. The … therapy resistance in triple-negative breast cancer. Immunity. March 28, … resistance in triple negative breast cancer. News Release. March …
-
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
07 Apr 2025 19:02 GMT
… the 42nd Annual Miami Breast Cancer Conference to discuss biomarkers … journey of a patient with breast cancer.
“It definitely can … estrogen receptors, progesterone receptors, HER2 that we've … receptors, progesterone receptors, and HER2, which we've …